Self-regulating diabetes implant could act as a tiny pancreas
A Technion-led team, collaborating with MIT, Harvard, and others, reports a living, cell-based implant that functions as a pancreas by sensing glucose and producing insulin within the device, protected from immune attack by a crystalline shield; tested in animals, it aims to provide a self-regulating diabetes treatment and may be adaptable to other chronic diseases, but human trials have not yet begun.
